Lung fibrosis drug study halted early
NCT ID NCT05497284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested new single treatments for idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and makes breathing hard. It included 46 adults aged 40 and older with mild to moderate IPF. The main goal was to see if the treatments improved lung function, measured by how much air they could exhale. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
CABA, Buenos Aires, C1056ABJ, Argentina
-
Novartis Investigative Site
Ranelagh Partido de Berazate, Buenos Aires, 1884, Argentina
-
Novartis Investigative Site
Paraná, 3100, Argentina
-
Novartis Investigative Site
Camperdown, New South Wales, 2050, Australia
-
Novartis Investigative Site
Chermside, Queensland, 4032, Australia
-
Novartis Investigative Site
Spearwood, Western Australia, 6163, Australia
-
Novartis Investigative Site
Prague, 140 59, Czechia
-
Novartis Investigative Site
Munich, Bavaria, 81377, Germany
-
Novartis Investigative Site
Coswig, 01640, Germany
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
Amsterdam, North Holland, 1081 HV, Netherlands
-
Novartis Investigative Site
Nieuwegein, Utrecht, 3435 CM, Netherlands
-
Novartis Investigative Site
Bialystok, 15-044, Poland
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of Kansas Hospital
Kansas City, Kansas, 66160, United States